ロード中...
Can pimavanserin help patients with Parkinson disease psychosis?
Pimavanserin is a first-in-class selective serotonin 5-HT(2A) receptor inverse agonist approved for the treatment of Parkinson disease psychosis. This article discusses pimavanserin’s mechanism of action, which patients are appropriate candidates for therapy, adverse reactions, and appropriate dosin...
保存先:
| 出版年: | JAAPA |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6764088/ https://ncbi.nlm.nih.gov/pubmed/30589736 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.JAA.0000547757.46299.3d |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|